CA3206326A1 - Methods of treating al amyloidosis - Google Patents

Methods of treating al amyloidosis Download PDF

Info

Publication number
CA3206326A1
CA3206326A1 CA3206326A CA3206326A CA3206326A1 CA 3206326 A1 CA3206326 A1 CA 3206326A1 CA 3206326 A CA3206326 A CA 3206326A CA 3206326 A CA3206326 A CA 3206326A CA 3206326 A1 CA3206326 A1 CA 3206326A1
Authority
CA
Canada
Prior art keywords
patient
treatment
meters
months
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3206326A
Other languages
English (en)
French (fr)
Inventor
Gene Kinney
Wagner Zago
Radhika TRIPURANENI
Carol KARP
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Protheima Biosciences Ltd
Original Assignee
Protheima Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protheima Biosciences Ltd filed Critical Protheima Biosciences Ltd
Publication of CA3206326A1 publication Critical patent/CA3206326A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Chemical Treatment Of Metals (AREA)
CA3206326A 2021-01-29 2022-01-29 Methods of treating al amyloidosis Pending CA3206326A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163143728P 2021-01-29 2021-01-29
US63/143,728 2021-01-29
PCT/IB2022/050785 WO2022162625A1 (en) 2021-01-29 2022-01-29 Methods of treating al amyloidosis

Publications (1)

Publication Number Publication Date
CA3206326A1 true CA3206326A1 (en) 2022-08-04

Family

ID=80222587

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3206326A Pending CA3206326A1 (en) 2021-01-29 2022-01-29 Methods of treating al amyloidosis

Country Status (13)

Country Link
US (1) US20250084153A1 (https=)
EP (1) EP4284829A1 (https=)
JP (1) JP2024505923A (https=)
KR (1) KR20230136643A (https=)
CN (1) CN117098775A (https=)
AU (1) AU2022213010A1 (https=)
CA (1) CA3206326A1 (https=)
CL (1) CL2023002236A1 (https=)
IL (1) IL304755A (https=)
JO (1) JOP20230172A1 (https=)
MX (1) MX2023008835A (https=)
TW (1) TW202332465A (https=)
WO (1) WO2022162625A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12021552135A1 (en) 2019-03-05 2022-08-31 Prothena Biosciences Ltd Methods of treating al amyloidosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018005967A1 (en) * 2016-06-30 2018-01-04 Prothena Therapeutics Limited Compositions for treating amyloidosis
US11382974B2 (en) * 2017-08-01 2022-07-12 The Trustees Of Columbia University In The City Of New York Methods and compositions for treatment of amyloid deposition diseases
PH12021552135A1 (en) * 2019-03-05 2022-08-31 Prothena Biosciences Ltd Methods of treating al amyloidosis

Also Published As

Publication number Publication date
US20250084153A1 (en) 2025-03-13
EP4284829A1 (en) 2023-12-06
JOP20230172A1 (ar) 2023-07-27
KR20230136643A (ko) 2023-09-26
IL304755A (en) 2023-09-01
CL2023002236A1 (es) 2024-02-09
CN117098775A (zh) 2023-11-21
AU2022213010A1 (en) 2023-08-17
WO2022162625A1 (en) 2022-08-04
AU2022213010A9 (en) 2024-09-26
TW202332465A (zh) 2023-08-16
JP2024505923A (ja) 2024-02-08
MX2023008835A (es) 2023-09-08

Similar Documents

Publication Publication Date Title
US12240894B2 (en) Methods of treating AL amyloidosis
US20210079078A1 (en) Compositions for Treating Amyloidosis
US20250084153A1 (en) Methods of treating al amyloidosis
US20250345418A1 (en) Methods of treating al amyloidosis
HK40066935B (en) An antibody for use in methods of treating al amyloidosis
HK40066935A (en) An antibody for use in methods of treating al amyloidosis
WO2025170969A1 (en) Methods of treating al amyloidosis
AU2022266821A9 (en) Anti-galectin-9 antibodies and therapeutic uses thereof
EA048260B1 (ru) Способы лечения al-амилоидоза
WO2025166118A1 (en) Dosage and administration of anti-c5 antibodies for treating iga nephropathy (igan)
CN121443637A (zh) 用于治疗斑块状银屑病的方法和组合物
WO2021207667A1 (en) Compositions and methods for treating lung injury or acute respiratory distress syndrome (ards)
CN119630422A (zh) 使用白细胞介素-17(il-17)拮抗剂治疗巨细胞动脉炎的方法

Legal Events

Date Code Title Description
MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250109

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250109

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250109

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260312